Search

Your search keyword '"Pamela J, Russell"' showing total 291 results

Search Constraints

Start Over You searched for: Author "Pamela J, Russell" Remove constraint Author: "Pamela J, Russell"
291 results on '"Pamela J, Russell"'

Search Results

1. A humanized orthotopic tumor microenvironment alters the bone metastatic tropism of prostate cancer cells

2. Targeted beta therapy of prostate cancer with 177Lu-labelled Miltuximab® antibody against glypican-1 (GPC-1)

3. Human Group IIA Phospholipase A2—Three Decades on from Its Discovery

4. Supplementary Data from Cytosine Deaminase-Uracil Phosphoribosyltransferase and Interleukin (IL)-12 and IL-18: A Multimodal Anticancer Interface Marked by Specific Modulation in Serum Cytokines

5. Data from Cytosine Deaminase-Uracil Phosphoribosyltransferase and Interleukin (IL)-12 and IL-18: A Multimodal Anticancer Interface Marked by Specific Modulation in Serum Cytokines

6. Human Group IIA Phospholipase A2—Three Decades on from Its Discovery

7. Plant-Derived MINA-05 Inhibits Human Prostate Cancer Proliferation In Vitro and Lymph Node Spread In Vivo

9. Macrophage inhibitory cytokine-1 (MIC-1/GDF15) gene deletion promotes cancer growth in TRAMP prostate cancer prone mice.

10. 3D Cultures of prostate cancer cells cultured in a novel high-throughput culture platform are more resistant to chemotherapeutics compared to cells cultured in monolayer.

12. A humanized orthotopic tumor microenvironment alters the bone metastatic tropism of prostate cancer cells

13. KLK4 Induces Anti-Tumor Effects in Human Xenograft Mouse Models of Orthotopic and Metastatic Prostate Cancer

14. Macrophage inhibitory cytokine-1 (MIC-1/GDF15) slows cancer development but increases metastases in TRAMP prostate cancer prone mice.

15. Paradoxical Roles of Tumour Necrosis Factor-Alpha in Prostate Cancer Biology

16. Zoledronic acid preserves bone structure and increases survival but does not limit tumour incidence in a prostate cancer bone metastasis model.

17. Localised delivery of doxorubicin to prostate cancer cells through a PSMA-targeted hyperbranched polymer theranostic

18. Gamma-Tocotrienol Induces Apoptosis in Prostate Cancer Cells by Targeting the Ang-1/Tie-2 Signalling Pathway

19. Neuropilin-1 is upregulated in the adaptive response of prostate tumors to androgen-targeted therapies and is prognostic of metastatic progression and patient mortality

20. Extracellular vesicles for personalized therapy decision support in advanced metastatic cancers and its potential impact for prostate cancer

21. Using prostate specific membrane antigen (PSMA) expression in clear cell renal cell carcinoma for imaging advanced disease

22. Modulation of paracrine signaling by CD9 positive small extracellular vesicles mediates cellular growth of androgen deprived prostate cancer

23. Humanization of the Prostate Microenvironment Reduces Homing of PC3 Prostate Cancer Cells to Human Tissue-Engineered Bone

24. Tie-2 regulates the stemness and metastatic properties of prostate cancer cells

25. Diet-induced hypercholesterolemia promotes androgen-independent prostate cancer metastasis via IQGAP1 and caveolin-1

26. Establishing Prostate Cancer Patient Derived Xenografts: Lessons Learned From Older Studies

27. Extracellular Vesicles in the Adaptive Process of Prostate Cancer during Inhibition of Androgen Receptor Signaling by Enzalutamide

28. Improved quality of risk-reducing salpingo-oophorectomy in Australasian women at high risk of pelvic serous cancer

29. Development of a polymer theranostic for prostate cancer

30. PTRF/cavin-1 neutralizes non-caveolar caveolin-1 microdomains in prostate cancer

31. Humanised xenograft models of bone metastasis revisited: novel insights into species-specific mechanisms of cancer cell osteotropism

32. Patient-Derived Xenograft Models of Prostate Tumors

33. Prostate Specific Membrane Antigen Positron Emission Tomography May Improve the Diagnostic Accuracy of Multiparametric Magnetic Resonance Imaging in Localized Prostate Cancer

34. Targeting Aurora Kinases: A Novel Approach to Curb the Growth & Chemoresistance of Androgen Refractory Prostate Cancer

35. Molecular Chemotherapy and Chemotherapy: A New Front against Late-Stage Hormone-Refractory Prostate Cancer

36. Adequacy of risk-reducing gynaecologic surgery in BRCA1 or BRCA2 mutation carriers and other women at high risk of pelvic serous cancer

37. Clinical pharmacology of isoflavones and its relevance for potential prevention of prostate cancer

38. Co-expression of CD147 (EMMPRIN), CD44v3-10, MDR1 and monocarboxylate transporters is associated with prostate cancer drug resistance and progression

39. Concise review: Nanoparticles and cellular carriers-allies in cancer imaging and cellular gene therapy?

40. Molecular and traditional chemotherapy: A united front against prostate cancer

41. Post-translation modification of proteins in tears

43. Innovative biomarkers for prostate cancer early diagnosis and progression

44. Radiotherapy is not associated with an increased rate of Second Primary Tumours in Oral Squamous Carcinoma: A study of 370 patients

45. Diagnosis of second head and neck tumors in primary laryngeal SCC is an indicator of overall survival and not associated with poorer overall survival: A single centre study in 987 patients

46. Stacked Search For Gravitational Waves From The 2006 Sgr 1900+14 Storm

47. A novel model of bone-metastatic prostate cancer in immunocompetent Mice

48. Mutant p53 and cyclin A1 protein expression in primary laryngeal squamous cell carcinomas do not correlate to second primary tumours of the head and neck*

49. Cytosolic Phospholipase A2-α: A Potential Therapeutic Target for Prostate Cancer

50. Preparation and testing of bevacizumab radioimmunoconjugates with Bismuth-213 and Bismuth-205 / Bismuth-206

Catalog

Books, media, physical & digital resources